Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme

被引：0
|
作者：
Kaname Ueda
Wenyu Ye
Louise Lombard
Atsushi Kuga
Yongin Kim
Sarah Cotton
James Jackson
Tamas Treuer
机构：
[1] Eli Lilly and Company,
[2] Lilly Corporate Center,undefined
[3] Adelphi Mill,undefined
[4] Grimshaw Lane,undefined
[5] Bollington,undefined
[6] Lilly Hungária Kft,undefined
来源：
The Journal of Headache and Pain | 2019年 / 20卷
关键词：
Chronic migraine; Episodic migraine; Migraine; Clinical practice; Treatment patterns; Patient-reported outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Real-world evidence of galcanezumab for migraine treatment in Japan: A retrospective analysis
    Takizawa, T.
    Ohtani, S.
    Watanabe, N.
    Miyazaki, N.
    Ishizuchi, K.
    Sekiguchi, K.
    Iba, C.
    Shibata, M.
    Takemura, R.
    Hori, S.
    Nakahara, J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [22] Real-world evidence on fremanezumab for migraine treatment in Japan: a retrospective analysis
    Takizawa, T.
    Ohtani, S.
    Watanabe, N.
    Ihara, K.
    Takahashi, N.
    Miyazaki, N.
    Ishizuchi, K.
    Takemura, R.
    Hori, S.
    Nakahara, J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [23] Real-world data on reductions in migraine and headache days with fremanezumab treatment for US patients with chronic and episodic migraine: Results from a physician chart review study
    Cohen, J. M.
    Thompson, S. F.
    Patterson-Lomba, O.
    Driessen, M. T.
    Seminerio, M. J.
    Carr, K.
    Mu, F.
    [J]. HEADACHE, 2021, 61 : 70 - 71
  • [24] A real-world analysis of outcomes in migraneurs receiving preventive migraine treatment
    Ford, J. H.
    Jackson, J.
    Milligan, G.
    Cotton, S.
    Ahl, J.
    [J]. HEADACHE, 2016, 56 : 66 - 66
  • [25] Patient-reported outcomes of migraine treatment with erenumab: results from a national patient survey
    Austėja Dapkutė
    Jurgita Vainauskienė
    Kristina Ryliškienė
    [J]. Neurological Sciences, 2022, 43 : 3305 - 3312
  • [26] Effectiveness of Galcanezumab on sleep, migraine and multidimensional patient-reperted outcome measures: A real-world experience in Turkish patients with episodic migraine and chronic migraine
    Aydinlar, Elif Ilgaz
    Soyukibar, Tuba Erdogan
    Dikmen, Pinar Yalinay
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 243 - 243
  • [27] Patient-reported outcomes of migraine treatment with erenumab: results from a national patient survey
    Dapkute, Austeja
    Vainauskiene, Jurgita
    Ryliskiene, Kristina
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (05) : 3305 - 3312
  • [28] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
    Driessen, Maurice T.
    Cohen, Joshua M.
    Thompson, Stephen F.
    Patterson-Lomba, Oscar
    Seminerio, Michael J.
    Carr, Karen
    Totev, Todor, I
    Sun, Rochelle
    Yim, Erica
    Mu, Fan
    Ayyagari, Rajeev
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [29] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
    Maurice T. Driessen
    Joshua M. Cohen
    Stephen F. Thompson
    Oscar Patterson-Lomba
    Michael J. Seminerio
    Karen Carr
    Todor I. Totev
    Rochelle Sun
    Erica Yim
    Fan Mu
    Rajeev Ayyagari
    [J]. The Journal of Headache and Pain, 2022, 23
  • [30] Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
    Blumenfeld, Andrew M.
    Patel, Atul T.
    Turner, Ira M.
    Mullin, Kathleen B.
    Manack Adams, Aubrey
    Rothrock, John F.
    [J]. JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
12345